Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Jones

Showing results (491-500 of 771) with videos related to

Pageof 78
Sort By:
BMC Bioinformatics|October 28, 2018
Tigmint: correcting assembly errors using linked reads from large moleculesShaun D Jackman, Lauren Coombe, Justin Chu, et al.
Genes, Chromosomes & Cancer|September 20, 2024
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic RhabdomyosarcomaVeronika Csizmok, Cameron J Grisdale, Laura M Williamson, et al.
Oncogene|February 1, 1991
Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomasJ D Ceci, R M Kovatch, D A Swing, et al.
Plos One|July 21, 2012
Twist1 transcriptional targets in the developing atrio-ventricular canal of the mousePavle Vrljicak, Rebecca Cullum, Eric Xu, et al.
The American Journal of Pathology|September 2, 2024
A Deep Learning Approach for the Identification of the Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Based on Whole Slide Pathology ImagesPouya Ahmadvand, Hossein Farahani, David Farnell, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
Arbovirus infection in a Murray Valley communityJ R Fraser, D G Christie, I D Gust, et al.
American Journal of Medical Genetics. Part A|December 12, 2025
Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing DataAna Acosta Bedón, Vahid Akbari, Ralph Rothstein, et al.
Plos One|September 17, 2010
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viabilityJennifer H Law, Yvonne Li, Karen To, et al.
Cell Reports|November 17, 2021
Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapyYiqun Zhang, Fengju Chen, Erin Pleasance, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous systemDerek Wong, Yaoqing Shen, Adrian B Levine, et al.
Pageof 78

Showing results (491-500 of 771) with videos related to

Sort By:
Pageof 78
BMC Bioinformatics|October 28, 2018
Tigmint: correcting assembly errors using linked reads from large moleculesShaun D Jackman, Lauren Coombe, Justin Chu, et al.
Genes, Chromosomes & Cancer|September 20, 2024
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic RhabdomyosarcomaVeronika Csizmok, Cameron J Grisdale, Laura M Williamson, et al.
Oncogene|February 1, 1991
Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomasJ D Ceci, R M Kovatch, D A Swing, et al.
Plos One|July 21, 2012
Twist1 transcriptional targets in the developing atrio-ventricular canal of the mousePavle Vrljicak, Rebecca Cullum, Eric Xu, et al.
The American Journal of Pathology|September 2, 2024
A Deep Learning Approach for the Identification of the Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Based on Whole Slide Pathology ImagesPouya Ahmadvand, Hossein Farahani, David Farnell, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
Arbovirus infection in a Murray Valley communityJ R Fraser, D G Christie, I D Gust, et al.
American Journal of Medical Genetics. Part A|December 12, 2025
Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing DataAna Acosta Bedón, Vahid Akbari, Ralph Rothstein, et al.
Plos One|September 17, 2010
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viabilityJennifer H Law, Yvonne Li, Karen To, et al.
Cell Reports|November 17, 2021
Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapyYiqun Zhang, Fengju Chen, Erin Pleasance, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous systemDerek Wong, Yaoqing Shen, Adrian B Levine, et al.
Pageof 78